Department of Orthopaedics, Changsha, Hunan, China.
Xiangya Hospital, Central South University, Hunan Key Laboratory of Joint Degeneration and Injury, Changsha, Hunan, China.
Arthroscopy. 2022 Oct;38(10):2897-2908.e18. doi: 10.1016/j.arthro.2022.03.013. Epub 2022 Mar 26.
To evaluate the comparative efficacy and safety of single-dose intra-articular injection of commonly used analgesics after knee arthroscopy.
A systematic literature review was done to search for randomized controlled trials (RCTs) published from database inception to October 1, 2020, that compared analgesics (i.e., morphine, bupivacaine, ropivacaine, and magnesium alone or in combination) with placebo or each other after knee arthroscopy. The primary outcomes were postoperative pain intensity at 2 hours and 24 hours. Secondary outcomes included the time to first analgesic request, number of patients requiring supplementary analgesics and side effects. We estimated summary standardized mean differences (SMDs) or odds ratios with 95% credible intervals (95% CrIs) using Bayesian network meta-analysis with random effects.
In total, 78 randomized controlled trials comprising 4,425 participants were included. Compared with placebo, magnesium plus bupivacaine was most likely to be effective in relieving pain at both 2-hour (SMD = -3.81, 95% CrI -5.28 to -2.35) and 24-hour after surgery (SMD = -2.81, 95% CrI: -4.29 to -1.30). Following was morphine plus bupivacaine (2-hour: SMD = -2.19, 95% CrI -3.05 to -1.31; 24-hour: SMD = -1.44, 95% CrI -2.14 to -0.73) and bupivacaine alone (2-hour: SMD = -1.66, 95% CrI -2.33 to -0.98; 24-hour: SMD = -0.67, 95% CrI -1.22 to -0.07); ropivacaine alone and magnesium alone were not effective on pain relief. The interval time to first analgesic request was significantly extended compared with placebo except for ropivacaine alone and magnesium alone. The number of patients requiring supplementary analgesics was reduced in all groups except ropivacaine alone. No statistically significant difference was found between any studied analgesics or placebo with regard to side effects.
Of 6 common postoperative intra-articular analgesics, magnesium plus bupivacaine provides the most effective pain relief without increasing short-term side effects after knee arthroscopy.
Level II, meta-analysis of Level I and II studies.
评估膝关节镜检查后单次关节内注射常用镇痛药的疗效和安全性。
系统检索数据库成立至 2020 年 10 月 1 日发表的随机对照试验(RCT),比较(即吗啡、布比卡因、罗哌卡因、镁单独或联合使用)与安慰剂或彼此之间膝关节镜检查后的镇痛效果。主要结局为术后 2 小时和 24 小时的疼痛强度。次要结局包括首次使用镇痛药的时间、需要补充镇痛药的患者人数和副作用。我们使用具有随机效应的贝叶斯网络荟萃分析来估计汇总标准化均数差(SMD)或优势比及其 95%可信区间(95%CrI)。
共纳入 78 项 RCT,包含 4425 名参与者。与安慰剂相比,镁加布比卡因在术后 2 小时(SMD=-3.81,95%CrI-5.28 至-2.35)和 24 小时(SMD=-2.81,95%CrI:-4.29 至-1.30)时缓解疼痛的效果最可能更优。其次是吗啡加布比卡因(2 小时:SMD=-2.19,95%CrI-3.05 至-1.31;24 小时:SMD=-1.44,95%CrI-2.14 至-0.73)和布比卡因单独使用(2 小时:SMD=-1.66,95%CrI-2.33 至-0.98;24 小时:SMD=-0.67,95%CrI-1.22 至-0.07);罗哌卡因单独使用和镁单独使用对疼痛缓解无效。与安慰剂相比,除了罗哌卡因单独使用和镁单独使用外,首次使用镇痛药的间隔时间明显延长。除了罗哌卡因单独使用外,所有组别的需要补充镇痛药的患者人数都减少了。在副作用方面,与任何研究的镇痛药或安慰剂相比,没有发现统计学上的显著差异。
在 6 种常见的膝关节镜术后关节内镇痛药物中,镁加布比卡因在不增加短期副作用的情况下提供最有效的疼痛缓解。
II 级,I 级和 II 级研究的荟萃分析。